VP Translational Biology: Nucleic Acid Delivery Leadership

Flagship Pioneering, Inc.; Somerville (MA); On-site; USD 180,000 - 240,000; Full time

Job summary

Mirai Bio is seeking a Head of Translational Biology to lead research on nucleic acid delivery for genomic medicines. The role focuses on developing non-viral vectors with cell-specific targeting and enhanced delivery, supporting next-generation genetic therapies.

The candidate will oversee discovery programs, design experiments, manage collaborations, and shape the strategy and resourcing for a high-impact translational biology group. This leadership position may be hybrid or onsite.

Qualifications

• Ph.D. in Immunology, Biochemistry, Pharmacology, or related field.
• 8+ years in in vivo delivery research within biopharma.
• Expertise in pharmacology, nucleic acid therapeutics, immunology, biodistribution.
• Prior management experience and strong communication skills.

Responsibilities

• Oversee discovery programs including in vivo proof-of-concept studies in animals.
• Design and troubleshoot experiments to advance nucleic acid delivery.
• Manage collaborations with industry partners and academic groups.
• Establish project timelines, priorities, and resource planning.
• Lead and develop a team of scientists and research associates.
• Present findings internally and externally to stakeholders.

Skills

Leadership

Project management

Communication

Problem solving

Collaboration

Education

Ph.D. in Immunology, Biochemistry, Pharmacology, or related

Tools

In vivo models

Job description

Mirai Bio is seeking a Head of Translational Biology to lead research on nucleic acid delivery for genomic medicines. The role focuses on developing non-viral vectors with cell-specific targeting and enhanced delivery, supporting next-generation genetic therapies.

The candidate will oversee discovery programs, design experiments, manage collaborations, and shape the strategy and resourcing for a high-impact translational biology group. This leadership position may be hybrid or onsite.